Establishment Labs (NASDAQ:ESTA – Get Free Report) announced its quarterly earnings data on Thursday. Here are the key takeaways from Establishment Labs’ conference call:Get Establishment Labs alerts:Positive Sentiment: Q2 revenue rose 31.7% year over year to $67.5 million, led by U.S. revenue growth of 140.9% to $24.7 million. Establishment Labs Price PerformanceShares of NASDAQ:ESTA traded down $12.20 during midday trading on Thursday, reaching $79.05. Establishment Labs Company Profile(Get Free Report)Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. Featured ArticlesReceive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.com's FREE daily email newsletter.